Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China · Delayed Price · Currency is CNY 53.61
-1.30 (-2.37%)
Oct 23, 2025, 10:45 AM CST
SHE:002294 Revenue
Shenzhen Salubris Pharmaceuticals had revenue of 1.07B CNY in the quarter ending June 30, 2025, with 12.30% growth. This brings the company's revenue in the last twelve months to 4.10B, up 10.12% year-over-year. In the year 2024, Shenzhen Salubris Pharmaceuticals had annual revenue of 4.01B with 19.22% growth.
Revenue (ttm)
4.10B
Revenue Growth
+10.12%
P/S Ratio
14.93
Revenue / Employee
1.14M
Employees
3,596
Market Cap
61.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.01B | 646.89M | 19.22% |
| Dec 31, 2023 | 3.37B | -116.67M | -3.35% |
| Jan 1, 2023 | 3.48B | 423.62M | 13.85% |
| Jan 1, 2022 | 3.06B | 319.83M | 11.68% |
| Dec 31, 2020 | 2.74B | -1.73B | -38.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |